Výsledky vyhledávání

Genetic Modifiers of Liver Disease in Cystic Fibrosis

Autor: Bartlett JR, Friedman KJ, Ling SC, Pace RG, Bell SC, Bourke B, Castellani C, Cipolli M, Colombo C, Colombo JL, Debray D, Fernandez A, Lacaille F, Macek M. Jr, Rowland M, Taylor CJ, Wainwright C, Wilschanski M, Zemková D, Hannah WB, Phillips MJ, Corey M, Zielenski J, Dorfman R, Wang Y, Zou, F, Silverman LM, Drumm ML, Wright FA, Lange EM, Durie PR, Knowles MR, Gene Modifier Study G.r.o.u.p. Collaborators: Clancy JP, Sindel LJ, Roberts DM, Roberts V, Radford PJ, Argel N, Morgan WJ, Douthit JL, Schellhase DE, Anderson P, Taggart A, Morrissey B, Platzker AC, Woo MS, Fukushima L, Hsu E, Shay GF, Hardy KA, Moss RB, Dunn CE, Pian MS, Wojtczak HA, Burns L, Henig NR, Nielson DW, Landon C, Thompson A, Accurso FJ, Nick JA, Jones M, Lapin C, Drapeau VM, Egan ME, Padman R, Winnie GB, George C, Olson EL, Light MJ, Geller DE, Gondor M, Flanary J, Stecenko AA, Guill MF, McColley SA, Potter EM, Chung Y, Garvey M, Howenstine MS, Sannuti A, Yeley J, Sloven DG, Ahrens RC, Teresi M, Riva CM, Davis S, Quiniones Ellis B, Gabor C, Lever TF, Welch R, Cairns A, Corrigan M, Zeitlin PL, Brass L, Dorkin H, Levy H, Huntington I, O'Sullivan BP, Simon RH, Nasr SZ, Lumeng N, Ball ME, Toder DS, Honicky RE, Fitch S, Contreras L, Regelmann WE, Phillips JR, McNamara J, Johnson M, Ruiz FE, Adcock KG, Konig P, Black P, Weigel JD, Noyes BE, Kociela VL, Ferkol T. Jr, Boyle M, Brascia T, Parker HW, Zanni RL, Fiel SB, Lomas P, Taylor Cousar J, Borowitz D, DeCelie Germana JK, Cohen R, Gannon M, DiMango EA, Mencin AA, Lobritto SJ, Benitez M, Walker PA, Berdella MN, Langfelder Schwind E, Ren CL, Rovitelli AK, Anbar RD, Lindner DM, Perciaccante RG, Dozor AJ, Leigh MW, Voynow JA, Auten KJ, Schechter MS, Omlor GJ, Ouellette DA, Karp CL, Joseph PM, Konstan MW, McCoy KS, Royce F, Bartosik S, Vauthy PA, Vauthy ML, Kramer JC, Hensel S, Perez CR, Thomas NJ, Hess JC, Holsclaw DS, Scanlin TF, Rubenstein R, Murray C, Skotleski M, Sexauer WP, Ko A, Hillman J, Orenstein DM, Flume PA, Brown D, Schoumacher R, Culbreath B, Moore PE, Slovis B, Dambro N, Garbarz J, Hiatt PW, Olivier KN, Amaro R, Macleod L, Liou TG, Froh DK, Epstein CE, Schmidt J, Elliot G, Williams R, Anderson M, Gadd J, Gibson RL, McNamara S, Worrell K, Moskowitz SM, McCarthy M, Llewellyn C, Wicks S, Moffett KS, Baer LS, do Pico GA, Makholm LM, Rock MJ, Osmond SR, Biller J, Miller T, Renteria F, Lewindon P, Selvadurai H, Gaskin K, Van Biervliet S, Montgomery M, Rabin HR, Leong J, Zuberbuhler P, Brown NE, Tabak J, Davidson AG, Nakielna EM, Habbick B, Waters I, Wiltse S, Kepron W, Pasterkamp H, Garey DN, Bishop G, Noseworthy M, Michael RT, Dale AM, Gosse FA, Robinson W, Freitag A, Pedder L, Van Wylick R, Lougheed MD, Kodiattu L, Jackson M, Malhotra K, Lyttle B, Paterson NA, Aaron S, Boland M, Kovesi T, Smith A, Kumar VJ, Zinger S, Tullis E, Simard F, Rivard L, Cantin A, Cote G, Lands LC, Marcotte JE, Matouk E, Berthiaume Y, Jeanneret A, Van Spall M, Rivard G, Boucher J, Petit N, Holmes B, Cotton D, Ramlall K, Repetto G, Vavrova V, Bartosova J, Fila L, Munck A, Tümmler B, Canny G, Gallagher C, Rivlin J, Picard E, Blau H, Springer C, Kerem E, Yahav Y, Bujanover Y, Casciaro R, Castaldo G, Salvatore F, Sinaasappel M, Dooijes D, Kayserova H, Ozcelik U, Kiper N, Dogru D, McGaw J., CASTALDO, GIUSEPPE, SALVATORE, FRANCESCO, RAIA, VALERIA

Publikováno v: ResearcherID

CONTEXT: A subset (approximately 3%-5%) of patients with cystic fibrosis (CF) develops severe liver disease with portal hypertension. OBJECTIVE: To assess whether any of 9 polymorphisms in 5 candidate genes (alpha(1)-antitrypsin or alpha(1)-antiprote

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5076f8190ed039c928c37df437d69ae6
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000269616200025&KeyUID=WOS:000269616200025

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání